Towards full control over protein glycosylation: in-vitro glycoengineering of 
influenza A virus hemagglutinin and SARS-CoV-2 spike protein

Juárez-Osorio, Mariana; Darr, Annabell; Volckmar, J.; Bruder, Dunja; Rexer, Thomas; Reichl, Udo

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

ポスター

Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein

MPS-Authors

/persons/resource/persons265619

Juárez-Osorio, Mariana
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons296998

Darr, Annabell
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons135949

Rexer, Thomas
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86448

Reichl, Udo
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U. (2023). Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein. Poster presented at GlycoBioTec 2023, Berlin, Germany.

引用: https://hdl.handle.net/21.11116/0000-000E-F56E-3

要旨

要旨はありません